- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05251467
A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF (CARDS-CF)
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Development of a Patient Reported Outcome Measure (PROM) in line with FDA guidance. The PROM is intended for daily use to measure the symptom burden of gastrointestinal symptoms for people with CF over the last 24 hours.
- Development of the initial conceptual framework underpinning the PROM and confirmed through a patient focus group.
- Primary item (question) generation for the PROM which will then be refined through a series of interviews with people with CF.
- Testing of the items through an online patient questionnaire for testing of frequency, burden and impact of the items.
- Piloting testing of the draft PROM daily for 2 weeks via smartphone app. The recall period of the PROM will be gastrointestinal symptom burden over the previous 24 hours.
Potential participant's will be identified through 6 UK CF care centres at Nottingham University Hospitals NHS Trust (paediatric and adult CF centres), Leeds Teaching Hospital NHS Trust, Manchester University NHS Foundation trust, Royal Brompton and Harefield NHS Foundation Trust and Kings College Hospital NHS Foundation Trust. In addition, recruitment for the survey and trialing the PROM on a smartphone app will also take place via social media and is therefore also open to people with CF from outside these CF centres.
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studiecontact
- Naam: Alan Smyth
- Telefoonnummer: 0115 8230612
- E-mail: alan.smyth@nottingham.ac.uk
Studie Contact Back-up
- Naam: Rebecca Calthorpe
- E-mail: rebecca.calthorpe@nottingham.ac.uk
Studie Locaties
-
-
-
Nottingham, Verenigd Koninkrijk, NG7 2UH
- Werving
- Nottingham University Hospitals NHS Trust
-
Hoofdonderzoeker:
- Alan Smyth
-
Contact:
- Alan Smyth
- E-mail: alan.smyth@nottingham.ac.uk
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- People with cystic fibrosis age 12 years and over
- Confirmed diagnosis of cystic fibrosis based on genotype or sweat chloride testing
- Capacity to consent, or to understand the requirements of the study where parental consent is required
Exclusion Criteria:
- < 12 years age
- Unable to give informed consent
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
People with CF age 12 years and over
Participants will be identified through one of the 6 participating UK CF centres as well as recruiting via social media.
Participants outside the 6 listed CF centres as well as outside the UK are also eligible.
|
Focus group to confirm PROM conceptual framework
Patient interviews to refine possible questions for the PROM
Online questionnaire to evaluate the proposed questions as part of PROM development in a larger population
Daily testing of the pilot PROM in a smartphone app for 2 weeks
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
To develop a new patient reported outcome measure (PROM) which will measure the daily gastrointestinal symptom burden for people with CF, with a recall period of 24 hours.
Tijdsspanne: 2 years
|
Development of a new PROM following FDA guidance which will measure the daily impact and burden of gastrointestinal symptoms for people with CF.
The recall period will be the previous 24 hours.
The name of the PROM will be decided as part of the development process.
Question development will be iterative.
Floor and ceiling effects for each of the questions will be assessed.
The CFAbd score will be used to assess construct validity of the newly developed PROM.
This will be completed alongside the PROM on days 1 and day 14.
|
2 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Measurement of adherence to daily data capture of the PROM through a smartphone app over a 2 week period
Tijdsspanne: 2 years
|
Adherence data - Percentage of completed PROM days over the 14 day period.
Percentage of completed CFabd scores on days 1 and 14.
This data will be collated through the research portal feedback facility in the app.
|
2 years
|
Attrition rate of participants
Tijdsspanne: 2 years
|
Attrition rate over the 2 weeks, define as people completing the app for two weeks (at least 10 out of 14 days) as a percentage of those initially who gave consent to take part and use the app.
|
2 years
|
Usability of the smartphone app
Tijdsspanne: 2 years
|
Usability of the app - participant feedback via the app on days 7 and 14 to include questions of ease of data entry on the app, whether they experience any technical issues with the app and whether questions are meaningful to participants.
These questions will be developed as part of the PROM development process.
|
2 years
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 21CS025
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Ziekten van de luchtwegen
-
University of PennsylvaniaVoltooidPatiënten met primaire of secundaire diagnose Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Behalve wanneer het 5e cijfer 2 was)Verenigde Staten
-
University Hospital, Strasbourg, FranceOnbekendAcute Respiratory Distress Syndrome na hartchirurgie onder cardiopulmonale bypassFrankrijk
-
Daping Hospital and the Research Institute of Surgery...307 Hospital of PLA; The First Affiliated Hospital of Anhui Medical University; Beijing 302 Hospital en andere medewerkersVoltooidNeonatale Acute Respiratory Distress Syndrome (ARDS)China
-
VA Office of Research and DevelopmentVoltooidCommunity Acquired Respiratory Disease SyndroomVerenigde Staten, Puerto Rico
-
Tanta UniversityWervingAcuut longletsel/acuut ademhalingsproblemensyndroom (ARDS) | Respiratory Distress Syndrome, pediatrischEgypte
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...WervingInfluenza | Nieuw respiratoir virus-1 Midden-Oosters respiratoir syndroom coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)Verenigde Staten, Australië, Spanje, Denemarken, Griekenland, Argentinië, Verenigd Koninkrijk, België, Chili, Duitsland, Peru, Thailand
-
Peking Union Medical College HospitalOnbekendARDS (Acute Respiratory Distress Syndrome) | Acute Cor PulmonaleChina
-
University Hospital, GhentVoltooidARDS (Acute Respiratory Distress Syndrome) | Respiratoire acidoseBelgië
-
University Hospital, GhentVoltooidVenoveneuze extracorporale CO2-verwijdering bij ARDS-patiënten om respiratoire acidose te behandelenACUTE RESPIRATORY DISTRESS SYNDROMEBelgië
-
University Hospital, AngersVoltooidAcuut longletsel | ARDS (Acute Respiratory Distress Syndrome) | Positieve eindexpiratoire druk (PEEP) | Elektrische impedantietomografie (EIT)Frankrijk
Klinische onderzoeken op Focus group
-
University of OxfordShoklo Malaria Research UnitVoltooidVroeggeboorte | Te vroeg geboren babyThailand
-
University of MichiganNational Cancer Institute (NCI); Wayne State University; Barbara Ann Karmanos Cancer... en andere medewerkersVoltooidBorstkanker | Colorectale kanker | Longkanker | ProstaatkankerVerenigde Staten
-
Nantes University HospitalOnbekend
-
Chinese University of Hong KongActief, niet wervendIntellectuele handicap, MildHongkong
-
Karadeniz Technical UniversityVoltooidHemodialyse | Eenzaamheid | Geluk | Aanpassing | Dierondersteunde therapie | SymptoomKalkoen
-
Federal University of Health Science of Porto AlegreVoltooidSpier zwakte | Spierzwakte Conditie | Nek; AfwijkingBrazilië
-
EgymedicalpediaVoltooidSteen, nier | Kind, alleenEgypte
-
University of MichiganVoltooid
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalVoltooid
-
Western Carolina UniversityTexas Woman's University; Mission Health System, Asheville, NCWerving